HDAC8 and nonpapillary renal cell carcinoma: Additionally, we showed that compared to overexpression of HDAC8 WT in ccRCC cells, overexpression of the HDAC8 S39D mutant did not further increase the IC50 value of sunitinib (Figure 4P).